NEWS CENTER

Successfully Concluded! RainMed Made a Stunning Appearance at High Tech Cardio 2023 Exhibition with Its Star Product caFFR

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2023-02-09 16:26
  • Views:

(Summary description)From February 1st to 3rd, 2023, the offline exhibition of High Tech Cardio Conference was grandly held at Palais du Pharo in Marseille, France. As one of the most prestigious exhibitions in Europe for sharing and exchanging cutting-edge technology and clinical treatment research of interventional cardiology, the exhibition has attracted many high-tech medical device companies and top European experts from all over the world. Exhibitors included medical device giants such as Abbott, Boston Scientific, Edwards LifeSciences, Medtronic and Philips. As a Chinese innovative company, RainMed was invited, showing the unique technical charm of its product caFFR.

Successfully Concluded! RainMed Made a Stunning Appearance at High Tech Cardio 2023 Exhibition with Its Star Product caFFR

(Summary description)From February 1st to 3rd, 2023, the offline exhibition of High Tech Cardio Conference was grandly held at Palais du Pharo in Marseille, France. As one of the most prestigious exhibitions in Europe for sharing and exchanging cutting-edge technology and clinical treatment research of interventional cardiology, the exhibition has attracted many high-tech medical device companies and top European experts from all over the world. Exhibitors included medical device giants such as Abbott, Boston Scientific, Edwards LifeSciences, Medtronic and Philips. As a Chinese innovative company, RainMed was invited, showing the unique technical charm of its product caFFR.

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2023-02-09 16:26
  • Views:
Information

From February 1st to 3rd, 2023, the offline exhibition of High Tech Cardio Conference was grandly held at Palais du Pharo in Marseille, France. As one of the most prestigious exhibitions in Europe for sharing and exchanging cutting-edge technology and clinical treatment research of interventional cardiology, the exhibition has attracted many high-tech medical device companies and top European experts from all over the world. Exhibitors included medical device giants such as Abbott, Boston Scientific, Edwards LifeSciences, Medtronic and Philips. As a Chinese innovative company, RainMed was invited, showing the unique technical charm of its product caFFR.

 

 

The diagnosis and treatment of coronary heart disease has always been a hot spot in global cardiovascular field. With the advent of aging, the change in people's lifestyle and the recurrence of COVID-19, the task of preventing and treating cardiovascular disease in the world is becoming increasingly difficult. Coronary heart disease is one of the most serious diseases in today's society in terms of morbidity, mortality and development trend. In the diagnosis of coronary artery stenosis, the traditional imaging diagnosis can only evaluate the degree of stenosis of the coronary artery. If there is a need to evaluate how much the stenosis has affected the distal blood flow and whether it has induced myocardial ischemia, the functional indicator -- fractional flow reserve (FFR) should be measured.

 

At the exhibition, RainMed, a medical device company from China, showcased its popular innovative product, an angiography-derived fractional flow reserve measurement system caFFR. As soon as it went on display, it attracted a lot of attention. caFFR is a coronary angiography-derived fractional flow reserve measurement system, which is based on two angiograms, real-time aortic pressure and a specially-designed computational fluid dynamics (CFD) model to measure FFR.  Compared with guidewire-based FFR, caFFR is relatively simple to operate, with low risk and short time. It avoids the use of invasive pressure guide wire and hyperemic agents, and therefore reduces the risk and cost for FFR measurement. With an extremely high diagnostic consistency of 95.7%, it provides clinicians an opportunity to expand the clinical application of coronary artery function evaluation.

 

The exhibition was a great success. Many visitors and customers visited RainMeds booth. The products on display also attracted lots of exhibitors to consult and negotiate. At the exhibition, RainMed announced its latest exploration in the field of coronary functional assessment, and also brought a caFFR prototype for audience to operate on site. RainMed Team also discussed the  product application with representatives of leading companies in the cardiovascular field, proposing new solutions to global cardiovascular disease.

 

RainMed's overseas business has covered more than 10 countries around the world. Adhering to the purpose of "Targeted medical services for people's health", RainMed will continue to pay attention to international market dynamics and demand in the future, expand business at home and abroad, firmly believe in professionalism and the power of continuous progress, to benefit more people around the world with high-quality diagnostic technology achievements

CONTACT US

0512-62622215

Address: Building 31, Northeast District, Nano City, No. 99 Jinji Lake Avenue, Suzhou industrial park

这是描述信息

WeChat public account

这是描述信息

Recruitment QR Code

We use cookies to improve our site and your shopping experience. By continuing to browse our site you accept our cookie policy. Find out more
close

Page Copyright© 2021- Suzhou Rainmed Medical Technology Co., Ltd.  苏公网安备32059002003601号  (苏)-非经营性-2021-0149